Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

10/01/2018 Guidelines for the Content of Statistical Analysis Plans in Clinical Trials 09/10/2017 Guidelines for Reporting on Latent Trajectory Studies (GRoLTS) 14/07/2017 A review of published analyses of case-cohort studies and recommendations for future reporting 14/07/2017 Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies 06/03/2017 Latent Class Analysis: An example for reporting results 06/03/2017 Guidelines for Developing and Reporting Machine Learning Predictive Models in Biomedical Research: A Multidisciplinary View 12/10/2016 REporting recommendations for tumour MARKer prognostic studies (REMARK) 03/08/2016 Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement 18/03/2016 Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers 10/08/2015 A call for transparent reporting to optimize the predictive value of preclinical research

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More